Transcriptional immune programs underlying inadequate response to tumor necrosis factor inhibitors in ankylosing spondylitis.
Inadequate response to tumor necrosis factor inhibitors (TNFi) in ankylosing spondylitis (AS) remains common. As the immunoregulatory and immunometabolic alterations across TNFi inadequate responder (TNFi-IR) subsets remain unexplored, we characterized molecular profiles across…